The possible relationships between hormone receptor status and several clinical (age, gynecologic history, clinical stage) and morphologic aspects (histologic grade, vascular invasion, lymphocytic infiltration, necrosis, fibrosis, elastosis and lymph node metastasis) were evaluated. A highly significant correlation between estrogen receptor levels, patient age, menses regularity and postmenopausal status was found. The histologic features most significantly related to tumor receptor status were histologic grade, lymphocytic infiltrate, necrosis and elastosis. Since these same histologic aspects appear to influence prognosis in breast cancer, the prognostic significance attributed to tumor receptor levels is substantiated. Therefore the importance of this assay is confirmed, not only for its diagnostic and therapeutic purposes, but also for its prognostic value.
Get full access to this article
View all access options for this article.
References
1.
AntoniadesK., SpectorH.: Correlation of estrogen receptor levels with histology and cytomorphology in human mammary cancer.Am. J. Clin. Pathol., 71: 497–503, 1979.
2.
Arslan PagniniC., Dalla PalmaP., De LaurentiisG.: Malignancy grading in squamous carcinoma of uterine cervix treated by surgery.Br. J. Cancer, 41: 415–421, 1980.
3.
Di PaolaM., AngeliniL., BertolottiA., CalizzaS.: Host resistance in relation to survival in breast cancer.Br. Med. J., 2: 268–270, 1974.
4.
E.O.R.T.C. Breast Cancer Cooperative Group.Standards for the assessment of estrogen receptors in human breast cancer. I° Workshop.Eur. J. Cancer, 9: 379–381, 1973.
5.
E.O.R.T.C. Breast Cancer Cooperative Group:Standards for the assessment of estrogen receptors in human breast cancer. II° Workshop.Eur. J. Cancer, 16: 1513–1515, 1–980.
6.
FisherE.R., GregorioR.M., FisherB.: The pathology of invasive breast cancer.A sillabus derived from findings of the National Surgical Adjuvant Breast Project (Protocol no. 4). Cancer, 36: 1–85, 1975.
7.
FisherE.R., PalekarA.S., GregorioR.M., RedmondC., FisherB.: Pathological findings from the National Surgical Adjuvant Breast Project (Protocol no.4). IV. Significance of tumor necrosis. Hum. Pathol., 9: 523–530, 1978.
8.
FisherE.R., RedmondC.K., LiuH., RocketteH., FisherB.: Correlation of estrogen receptor and pathologic characteristics of invasive breast cancer.Cancer, 45: 349–353, 1980.
9.
FreedmanL.S., EdwardsD.N., McConnellE.M., DownhamD.Y.: Histological grade and other prognostic factors in relation to survival of patients with breast cancer.Br. J. Cancer, 40: 44–55, 1979.
10.
FuY.S., MaksenJ.A., HubayC.A., TemmimL., ReaganJ.W.: The relationship of breast cancer morphology and estrogen receptor protein status. In: Progress in Surgical Pathology, vol. III.FenoglioC.M., and WolffM. (Eds.), pp. 65–76, Masson, New York, 1981.
11.
FumeroS., BerrutoG.P., PelizzolaD., GrilliS., PiffanelliA.: Results of the Italian Interlaboratory Quality Control Program for estradiol receptor assay.Tumori, 67: 301–306, 1981.
12.
GlaubitzL.C., BowenJ.H., CoxE.B., McCartyK.S.Jr.: Elastosis in human breast cancer.Arch. Pathol. Lab. Med., 108: 27–30, 1984.
13.
HähnelR., WoodingsT., VivianA.B.: Prognostic value of estrogen receptor in primary breast cancer.Cancer, 44: 671–675, 1979.
14.
HilfR., FeldsteinM.L., GibsonS.L., SavlovE.D.: The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer.Cancer, 45: 1993–2000, 1980.
15.
KnightW.A., LivingstonR.B., GregoryE.J., McGuireW.L.: Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.Cancer Res., 37: 4669–4671, 1977.
16.
Le DoussalV., PichonM.F., PalludC., HaceneK., GestJ., MilgromE.: Relationship between ultrastructure and receptor content of human primary breast cancer.Histopathology, 8: 89–103, 1984.
17.
MaynardP.V., DaviesC.J., BlarneyR.W., ElstonC.W., JohnsonJ., GriffithsK.: Relationship between oestrogen receptor content and histological grade in human primary breast tumors.Br. J. Cancer, 38: 745–748, 1978.
18.
MartinP.M., JacquemierJ., RollandP.H., RollandA.M., TogaM.: Tumeurs mammaires humaines: corrélation entre les récepteurs hormonauux stéroidiens et l'anatomie pathologique.Bull. Cancer, 45: 383–388, 1978.
19.
MastersJ.R.W., SangsterK., HowkinsR.A., ShivasA.: Elastosis and oestrogen receptors in human breast cancer.Br. J. Cancer, 33: 342–343, 1976.
20.
MastersJ.R.W., HowkinsR.A., SangsterK.: Oestrogen receptor, cellularity elastosis and menstrual status in human breast cancer.Eur. J. Cancer, 14: 303–307, 1978.
21.
MastersJ.R.W., MillisR.R., KingR.J.B., RubensR.D.: Elastosis and response to endocrine therapy in human breast cancer.Br. J. Cancer, 39: 356–359, 1979.
22.
McCartyK.S.Jr., BartonT.K., FetterB.F., WoodardB.H., MossierJ.A., ReevesW., DalyJ., WilkinsonW.E., McCartyK.S.Sr.: Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.Cancer, 46: 2851–2858, 1980.
23.
MillisR.: Correlation of hormone receptor with pathological features in human breast cancer.Cancer, 46: 2869–2871, 1980.
24.
ParlF.F., WagnerR.K.: The histopathological evaluation of human breast cancers in correlation with estrogen receptor values.Cancer, 46: 362–367, 1980.
25.
PichonM.F., PalludC., BrunetM., MilgronE.: Utilisation à visée pronostique des résultats de mesure de récepteurs de l'oestradiol et de la progestérone dans le cancer du sein.Senologia, 6: 97–100, 1981.
26.
PiffanelliA., FumeroS., PelizzolaD., BerrutoG.P., RicciL., GiovanniniG.: Uniformed D.C.C.method for estradiol and progesterone assay on tumor tissue. LAB, 9: 13–21, 1982.
27.
PiffanelliA., FumeroS., PelizzolaD., De BartoliM., GiovanniniG., TosiS.P.: Quality control of estradiol receptor assay the Italian experience.I.A.E.A. Radioimmunoassay and related procedures in medicine1982: pp. 635–644, 1983.
28.
PoulsenH.S., OzzelloL., AndersenJ.: Oestrogen receptors in human breast cancer.Problems of correlation with histopathological features. Virchows Arch. (Pathol. Anat.), 397: 103–108, 1982.
29.
RichM.A., FurmanskiP., BrooksS.C.: Prognostic value of estrogen receptor determinations in patients with breast cancer.Cancer Res., 38: 4296–4298, 1978.
30.
RobertsonA.J., BrownR.A., CreeI.A., MacGillivrayJ.B., SliddersW., Swanson BeckJ.: Prognostic value of the measurement of elastosis in breast carcinoma.J. Clin. Pathol., 34: 738–743, 1981.
31.
SampatM.B., SirsatM.V., GangadharanP.: Prognostic significance of blood vessel invasion in carcinoma of the breast in women.J. Surg. Oncol., 9: 623–632, 1977.
32.
SilfverswärdC., GustafssonJ., GustafssonS.A., HumlaS.A., NordenskjöldB., WallgrenA., WrangeO.: Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer.Cancer, 45: 2001–2005, 1980.
33.
UICC-TNM Classificazione dei tumori maligni.Minerva Medica, 1979.
34.
World Health Organization. Histological Typing of Breast Tumours, 2nd ed., W.H.O., Geneva, 1981.
